The early signs are sensory and they start in the toes: burning at night, tingling, and numbness that spreads upward on both feet at once. Diabetic peripheral neuropathy occurs in up to 50% of patients with diabetes mellitus and commonly presents as distal symmetric polyneuropathy with a stocking-and-glove distribution, starting in the toes and moving proximally.1 Recognizing the pattern early matters because the same paper links it to loss of protective sensation and the cascade into foot ulcers, wounds and infections.1
What the early pattern looks like
These changes rarely feel like an emergency at first. People describe them as being in the socks, on the skin, or in the floor underfoot.
- Burning in the feet that is worse at night or after lying down
- Tingling or pins-and-needles in the toes or forefoot
- Numbness that starts small and spreads upward
- Brief electric or stabbing pains
- Unsteadiness on uneven ground or in the dark
The symmetry is the diagnostic clue. A problem in one foot alone points somewhere else; the same change in both feet, worst at the toes, fits a length-dependent process.
Why numbness is the more dangerous symptom
Pain gets attention. Numbness does not, which is exactly the problem: American Family Physician notes that diabetic peripheral neuropathy may result in a loss of protective sensation and cascade into foot ulcers, wounds, infections and tissue necrosis.1
Once protective sensation is reduced, a blister or a stone in the shoe no longer announces itself. That is the point at which daily foot inspection stops being optional.
Why a normal A1C does not settle the question
Fasting glucose and A1C describe circulating sugar at a point in time. They are not a direct measure of the metabolic state around the nerve, and a result inside the reference range does not by itself rule out an early neuropathic process.
In our clinic we look at insulin resistance and the wider metabolic picture rather than relying on A1C alone. The reasoning is set out in blood sugar and nerve damage, and why normal labs miss it.
Where chronic hyperglycemia is present, glycation is one of the mechanisms by which sugar damages nerve tissue over time. We explain it in how glycation damages nerves.
Other drivers that can be present at the same time
Neuropathy is a category, not a diagnosis, and a diabetes diagnosis does not exclude a second cause. American Family Physician specifically directs physicians to address underlying risk factors including vitamin B12 deficiency alongside glycemic control.1
Nutritional, autoimmune, toxic and structural drivers all produce foot symptoms, and treating only the one you assumed is how a plan stalls. Identifying which driver is doing the most damage is the first job of the evaluation.
What evaluation and care look like at Regenerve
We perform electrodiagnostic testing (EMG/NCS) on site, and we sort between metabolic, nutritional, autoimmune, toxic and structural drivers before building a plan. Where balance is involved, VNG is used as a diagnostic test of inner-ear balance function, not as a treatment.
Care options include physician-directed metabolic and nutritional care, class 4 photobiomodulation, class 3B cold laser and whole-body infrared. Orthobiologic injections (PRP and BMAC) are offered in selected situations. Qutenza (capsaicin 8% patch) is FDA-approved in adults only for neuropathic pain from postherpetic neuralgia and from diabetic peripheral neuropathy of the feet; it is applied in clinic by a clinician and repeated no more often than every three months.
We do not promise nerve regeneration, reversal or cure, and we do not publish a success rate for our protocol. We are at 4477 Woodson Rd #104, St. Louis, MO 63134, and we see patients from the St. Louis region, Missouri and Illinois.
What to do this week
- Check both feet daily, soles included, using a mirror if you cannot see them.
- Write down when the burning is worst and whether it is spreading.
- Wear shoes that do not create pressure points, and check inside them before putting them on.
- Ask for a work-up that looks past A1C, including B12 status.
- Get evaluated rather than waiting for the pain to make the decision for you.
Start with your Nerve Damage Score
If you recognize the pattern, do not wait for it to spread. The Nerve Damage Score is a free five-question screen that helps identify which driver to test for first.
Frequently asked questions
What are the earliest signs of diabetic peripheral neuropathy?
Sensory changes in the toes come first: burning at night, tingling, and numbness that spreads upward in a symmetric pattern. American Family Physician describes the presentation as distal symmetric polyneuropathy with a stocking-and-glove distribution, starting in the toes and moving proximally. See peripheral neuropathy of the feet symptoms.
My nerve testing was normal but my feet burn at night. What now?
Standard nerve conduction studies are weighted toward large myelinated fibers, so a small-fiber problem can sit beneath a normal result. Burning, temperature changes and altered sweating are the pattern worth raising. See small fiber neuropathy symptoms and testing.
Can I have nerve symptoms from something other than blood sugar?
Yes, and more than one driver can be present at the same time. Nutritional, autoimmune, toxic and structural causes all produce foot symptoms, which is why the work-up looks past the diabetes label. See why a normal B12 result can still miss neuropathy.
Is numbness better than pain?
No. Loss of protective sensation is what allows an injury to go unnoticed, and American Family Physician links it to the development of foot ulcers, wounds and infections. Numbness is a reason to start daily foot checks, not to relax. See exercises for peripheral neuropathy in the feet.
Sources
- Bragg S, Marrison ST, Haley S. “Diabetic Peripheral Neuropathy: Prevention and Treatment.” American Family Physician. 2024;109(3):226. https://www.aafp.org/afp/2024/0300/diabetic-peripheral-neuropathy
- Hicks CW, Selvin E. “Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.” Current Diabetes Reports. 2019;19(10):86. https://pmc.ncbi.nlm.nih.gov/articles/PMC6755905/